Literature DB >> 22124751

A simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized L-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges.

Joe M El-Khoury1, Dustin R Bunch, Edmunds Reineks, Raymond Jackson, Roxanne Steinle, Sihe Wang.   

Abstract

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase and an established biomarker for endothelial function, while symmetric dimethylarginine (SDMA), an emerging biomarker for renal function, has been shown to outperform creatinine-based equations for estimated glomerular filtration rate. In order to study these analytes for clinical research, a fast and simple method for measuring arginine (ARG), SDMA, and ADMA in plasma by liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been developed. Plasma (50 μL) was mixed with 50 μL of internal standard of (13)C-arginine and d(7)-ADMA followed by protein precipitation with methanol containing 1% ammonium acetate (300 μL). After centrifugation, the supernatant (100 μL) was mixed with 300 μL of acetonitrile with 1% formic acid, and the mixture was injected onto a silica column monitored by a mass spectrometer. The analytical cycle time was 5.0 min. The method was linear from 5.7 to 489.7 μM for ARG, 0.06 to 5.15 μM for SDMA, and from 0.34 to 5.65 μM for ADMA, with an accuracy of 99.0-120.0%. Total coefficients of variation for all analytes ranged from 2.7% to 7.7% for three concentration levels. The effects of hemolysis, lipemia, uremia, icterus, specimen tube types, storage at different temperature, and freeze/thaw were thoroughly investigated. Reference ranges were established using 51 well-defined reference subjects (12 men and 39 women, age 19-64 years): 53.1-129.7 μM for ARG, 0.32-0.65 μM for SDMA, and 0.36-0.67 μM for ADMA. In conclusion, the validated LC-MS/MS method described here offers a fast and reliable ARG, SDMA, and ADMA quantitation in plasma with minimum sample preparation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22124751     DOI: 10.1007/s00216-011-5462-9

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  9 in total

1.  Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.

Authors:  Tariq Shafi; Thomas H Hostetter; Timothy W Meyer; Seungyoung Hwang; Xin Hai; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2017-01-12       Impact factor: 8.860

2.  Evaluation of Renal Biomarkers, Including Symmetric Dimethylarginine, following Gentamicin-Induced Proximal Tubular Injury in the Rat.

Authors:  Diane M Hamlin; A Eric Schultze; Michael J Coyne; Donald J McCrann; Rebekah Mack; Corie Drake; Rachel E Murphy; Julie Cross; Marilyn Strong-Townsend; Maha Yerramilli; Mary K Leissinger
Journal:  Kidney360       Date:  2021-12-07

3.  Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study.

Authors:  Anders Jorgensen; Ulla Knorr; Mia Greisen Soendergaard; Jens Lykkesfeldt; Anders Fink-Jensen; Henrik Enghusen Poulsen; Martin Balslev Jorgensen; Niels Vidiendal Olsen; Jonatan Myrup Staalsø
Journal:  BMC Psychiatry       Date:  2015-04-03       Impact factor: 3.630

4.  Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration.

Authors:  Matthew S Alkaitis; Glenn Nardone; Jessica H Chertow; Hans C Ackerman
Journal:  Biomed Chromatogr       Date:  2015-07-30       Impact factor: 1.902

5.  Developing a robust, fast and reliable measurement method for the analysis of methylarginine derivatives and related metabolites.

Authors:  Duygu Eryavuz Onmaz; Sedat Abusoglu; Havva Yaglioglu; Gulsum Abusoglu; Ali Unlu
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2021-03-06

Review 6.  Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Authors:  Luis Aldámiz-Echevarría; Fernando Andrade
Journal:  Int J Mol Sci       Date:  2012-09-10       Impact factor: 6.208

7.  Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA.

Authors:  Jente Boelaert; Eva Schepers; Griet Glorieux; Sunny Eloot; Raymond Vanholder; Frédéric Lynen
Journal:  Toxins (Basel)       Date:  2016-05-13       Impact factor: 4.546

8.  Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine.

Authors:  Juliane Hannemann; Thore I Roskam; Ina Eilermann; Patricia Siques; Julio Brito; Rainer Böger
Journal:  J Clin Med       Date:  2020-04-09       Impact factor: 4.241

9.  Liquid chromatography as candidate reference method for the determination of vitamins A and E in human serum.

Authors:  Qingqing Pan; Min Shen; Ting Yu; Xiaodong Yang; Quanle Li; Beibei Zhao; Jihua Zou; Man Zhang
Journal:  J Clin Lab Anal       Date:  2020-10-08       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.